KRYS
KRYS
NASDAQ · Biotechnology

Krystal Biotech Inc

$350.88
+17.03 (+5.10%)
As of Sep 22, 9:47 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 17 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -75.3% upside
Low Target $54.31
Average Target $86.77
High Target $114.95
Current Price $350.88
Current
$350.88
Target
$86.77
$54.31 $86.77 avg $114.95
Scenario Analysis
Bear Case
$54.31
-84.5%
Low target
Base Case
$86.77
-75.3%
Avg target
Bull Case
$114.95
+-67.2%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$382.54
-8.3% from high
52-Week Low
$153.20
+129.0% from low
50-Day SMA
$263.07
+33.4% vs SMA
200-Day SMA
$186.47
+88.2% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$86.77
-77.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%